HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/4/R991    most recent 00207.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Mattson, D. L. Articles by Meister, C. J. Search for Related Content PubMed PubMed Citation Articles by Mattson, D. L. Articles by Meister, C. J.

RENAL HEMODYNAMICS AND CARDIORENAL INTEGRATION

Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice

Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin

Submitted 25 March 2005 ; accepted in final form 9 June 2005

Experiments in wild-type (WT; C57BL/6J) mice, endothelial nitric oxide synthase null mutant [eNOS(-/-)] mice, and neuronal NOS null mutant [nNOS(-/-)] mice were performed to determine which NOS isoform regulates renal cortical and medullary blood flow under basal conditions and during the infusion of ANG II. Inhibition of NOS with N-nitro-L-arginine methyl ester (L-NAME; 50 mg/kg iv) in Inactin-anesthetized WT and nNOS(-/-) mice increased arterial blood pressure by 28–31 mmHg and significantly decreased blood flow in the renal cortex (18–24%) and the renal medulla (13–18%). In contrast, blood pressure and renal cortical and medullary blood flow were unaltered after L-NAME administration to eNOS(-/-) mice, indicating that NO derived from eNOS regulates baseline vascular resistance in mice. In subsequent experiments, intravenous ANG II (20 ng·kg^–1·min^–1) significantly decreased renal cortical blood flow (by 15–25%) in WT, eNOS(-/-), nNOS(-/-), and WT mice treated with L-NAME. The infusion of ANG II, however, led to a significant increase in medullary blood flow (12–15%) in WT and eNOS(-/-) mice. The increase in medullary blood flow following ANG II infusion was not observed in nNOS(-/-) mice, in WT or eNOS(-/-) mice pretreated with L-NAME, or in WT mice administered the nNOS inhibitor 5-(1-imino-3-butenyl)-L-ornithine (1 mg·kg^–1·h^–1). These data demonstrate that NO from eNOS regulates baseline blood flow in the mouse renal cortex and medulla, while NO produced by nNOS mediates an increase in medullary blood flow in response to ANG II.

kidney; nitric oxide synthase; laser-Doppler flowmetry; mice; angiotensin II; endothelial and neuronal nitric oxide synthase; N-nitro-L-arginine

This article has been cited by other articles:

				J. Stegbauer, Y. Kuczka, O. Vonend, I. Quack, L. Sellin, A. Patzak, A. Steege, K. Langnaese, and L. C. Rump Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R421 - R428. [Abstract] [Full Text] [PDF]

				S. M. Fitzgerald, B. K. Kemp-Harper, H. C. Parkington, G. A. Head, and R. G. Evans Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R707 - R713. [Abstract] [Full Text] [PDF]

				W. Kim, S.-O. Moon, S. Y. Lee, K. Y. Jang, C.-H. Cho, G. Y. Koh, K.-S. Choi, K.-H. Yoon, M. J. Sung, D. H. Kim, et al. COMP-Angiopoietin-1 Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Model J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2474 - 2483. [Abstract] [Full Text] [PDF]

				P. B. Persson Fluid volume or arterial pressure, that is the question J. Physiol., September 1, 2005; 567(2): 361 - 361. [Full Text] [PDF]